Colombia INVIMA registration INVIMA 2021RD-0006816

SARS-COV-2 ANTIGEN (GICA)

Name: SARS-COV-2 ANTIGEN (GICA) — Colombia INVIMA registration INVIMA 2021RD-0006816
Creator: QUIMIOLAB S.A.S
Keywords: SARS-COV-2 ANTIGEN (GICA), INVIMA 2021RD-0006816, III, INVIMA registration

SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.IIIColombia INVIMAExpires April 03, 2029

VerifiedINVIMA · official registry

Device classification

Registered product (Spanish): SARS-COV-2 ANTIGEN (GICA)
Risk class / Clase de riesgo: III
Product group (Spanish): REACTIVO DIAGNOSTICO

Registration information

Sanitary registration: INVIMA 2021RD-0006816
Expediente: 20199268
Status / Estado: Cancelled
Expiry date: April 03, 2029

Registration holder / Titular

Name: QUIMIOLAB S.A.S

Associated party / Rol

Name: SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.
Role: FABRICANTE
Country: CHINA
Manufacturer: SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.

About this record

Access comprehensive regulatory information for SARS-COV-2 ANTIGEN (GICA) in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA sanitary registration INVIMA 2021RD-0006816, held by QUIMIOLAB S.A.S and associated with SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD. (FABRICANTE). The registration expires on April 03, 2029.

This page provides complete registration details including product group (REACTIVO DIAGNOSTICO), holder and associated-party information, and regulatory data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.